JP Morgan Sec LLC

AbbVie Inc. 38.5(b) Amendment

RNS Number : 6868L
J.P. Morgan Securities LLC
01 May 2020
 

Ap27

 

 

AMENDMENT

FORM   38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED 
INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

J.P Morgan Securities LLC

Companydealtin

AbbVie Inc.

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

Common stock

Date of dealing

30 April 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

 12,619,636  0.85

 4,288,418  0.29

(2) Derivatives (other than options)

 6,048,931  0.41

 7,739,431  0.52

(3)Optionsandagreementstopurchase/sell

 756,700  0.05

 758,000  0.05

Total

  19,425,267  1.31

 12,785,849  0.86

             

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   2)

 

Classofrelevantsecurity:

Long

Short

 

Number

 

(%)

Number

 

(%)

 

 

(2) Derivatives (other than options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

 

Ap28

 

 

3.  DEALINGS  (Note   3)

 

(a)  Purchases and sales

 

Purchase/sale

Numberofrelevantsecurities

Priceperunit (Note 4)

Purchase (New Borrow)

 

Purchases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

1,557,600

 

85

100

97

700

101,021

100

49

500

1,200

1,500

7,170

8,600

100

276

200

75

728

507

100

1,200

100

100

130

800

17

50

1,718

200

1,000

174

2,194

600

40

174

503

100

260

20

170

 

50

93

84

34

100

100

100

700

6,861

17

2,800

548

100

100

100

100

25

100

100

100

2,400

100

2,703

100

100

34

100

17

100

100

50

78

50

81,904

2,216

100

50

8,600

100

728

134

12

300

22

22

50

21

37

170

120

NA

 

82.0000 USD

82.0786 USD

82.1200 USD

82.1771 USD

82.2000 USD

82.2033 USD

82.2100 USD

82.2260 USD

82.2327 USD

82.2393 USD

82.2400 USD

82.2413 USD

82.2436 USD

82.2465 USD

82.2473 USD

82.2700 USD

82.2789 USD

82.2790 USD

82.3000 USD

82.3092 USD

82.3129 USD

82.3200 USD

82.3300 USD

82.3313 USD

82.3400 USD

82.3424 USD

82.3437 USD

82.3464 USD

82.3468 USD

82.3500 USD

82.3502 USD

82.3617 USD

82.3800 USD

82.3845 USD

82.3855 USD

82.3900 USD

82.3923 USD

82.5200 USD

82.9088 USD

 

81.2990 USD

81.5200 USD

81.5600 USD

81.5906 USD

81.6742 USD

81.8244 USD

81.8306 USD

81.8343 USD

81.8476 USD

81.8700 USD

81.9011 USD

81.9061 USD

81.9096 USD

81.9106 USD

81.9199 USD

81.9370 USD

81.9400 USD

81.9425 USD

81.9577 USD

81.9770 USD

81.9842 USD

81.9890 USD

81.9894 USD

82.0144 USD

82.0219 USD

82.0451 USD

82.0541 USD

82.0875 USD

82.1079 USD

82.1397 USD

82.1515 USD

82.1700 USD

82.1832 USD

82.2000 USD

82.2020 USD

82.2033 USD

82.2360 USD

82.2413 USD

82.2637 USD

82.2789 USD

82.2790 USD

82.2800 USD

82.2967 USD

82.3100 USD

82.4000 USD

82.4500 USD

82.5000 USD

82.6200 USD

82.9088 USD

83.1000 USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 5)

Numberofrelevantsecurities

(Note 6)

Priceperunit

(USD)

(Note 4)

Equity Swaps

Long

 

Short

170

 

40

100

8,600

728

82.9088

 

82.2000

82.2033

82.2413

82.2789

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 4)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 4)

 

 

 

 

 

(d)  Other   dealings   (including   transactions   in   respect   of   new   securities)   (Note   3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Ap29

 

4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities 
under any option referred to on this form or relating to the voting rights or future 
acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached?  (Note   8)    YES

 

 

Dateofdisclosure

1 May 2020

Contactname

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

Allergan plc

Nature of connection (Note 9)

Financial Advisor to Allergan plc

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ap31

 

 

SUPPLEMENTAL   FORM   38.5(b)

 

 

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   38.5(b))   OPEN POSITIONS  (Note   1)

 

Productname,

e.g. call option

Written orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

10,000

6,100

41,200

8,400

11,200

7,200

21,100

2,500

7,900

5,600

2,500

8,500

10,000

100,000

50,000

15,000

15,000

20,000

7,900

9,500

8,500

6,100

18,200

8,400

11,200

7,200

21,100

2,500

4,500

5,600

2,500

20,000

15,000

15,000

20,000

102,500

31,300

32,300

16,400

65,000

900

7,000

4,400

45,000

29,100

9,700

4,900

12,100

12,100

800

140,000

5,100

3,000

600

20,000

15,000

15,000

20,000

102,500

31,300

32,300

11,400

8,900

1,900

4,400

29,100

20,000

100,000

15,000

15,000

20,000

1,600

1,200

700

1,800

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

105.00

110.00

70.00

92.50

91.57

95.93

82.37

95.00

100.00

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

82.50

91.57

95.93

82.37

60.00

65.00

70.00

75.00

77.50

85.00

72.50

67.50

80.00

55.00

60.00

65.00

70.00

75.00

77.50

82.50

62.50

72.50

67.50

80.00

78.49

82.85

78.35

60.00

65.00

70.00

75.00

77.50

72.50

67.50

55.00

60.00

70.00

78.49

82.85

78.35

75.00

77.50

72.50

80.00

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

18SEP20

18SEP20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

18SEP20

18SEP20

18SEP20

18SEP20

 

 

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rules 8 and

38.5 of the Rules. If in doubt, consult the Panel.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBBGDUGDGDGGB